Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-28T01:53:02.684Z Has data issue: false hasContentIssue false
  • English
  • Français

The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia

Published online by Cambridge University Press:  01 July 2010

K. de Medeiros ,
P. Robert ,
S. Gauthier ,
F. Stella ,
A. Politis ,
J. Leoutsakos ,
F. Taragano ,
J. Kremer ,
A. Brugnolo  and
A. P. Porsteinsson
...Show all authors
K. de Medeiros*
Affiliation:
The Copper Ridge Institute, Sykesville, Maryland, U.S.A. Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.
P. Robert
Affiliation:
Centre Mémoire de Ressources et de Recherche – CHU – Nice–Sophia Antipolis University, France
S. Gauthier
Affiliation:
McGill Center for Studies in Aging, Montreal, Canada
F. Stella
Affiliation:
UNESP – São Paulo State University, Biosciences Institute, Rio Claro, SP, Brazil
A. Politis
Affiliation:
Division of Geriatric Psychiatry, Egnition Hopsital, Athens Hospital, Athens, Greece
J. Leoutsakos
Affiliation:
Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. Department of Psychiatry, Johns Hopkins Bayview, Baltimore, Maryland, U.S.A.
F. Taragano
Affiliation:
CEMIC, University Hospital Dementia Research Unit, Buenos Aires, Argentina
J. Kremer
Affiliation:
Institute Privado Kremer, Cordoba, Argentina
A. Brugnolo
Affiliation:
Department of Neurosciences, DINOG, Genoa, Italy
A. P. Porsteinsson
Affiliation:
AD-CARE, University of Rochester School of Medicine and Dentistry, Rochester, New York, U.S.A.
Y. E. Geda
Affiliation:
Mayo Clinic, Rochester, Minnesota, U.S.A.
H. Brodaty
Affiliation:
Dementia Collaborative Research Centre, University of South Wales, Sydney, Australia
G. Gazdag
Affiliation:
1st Department of Psychiatry and Psychiatric Rehabilitation, Jahn Ferenc Hospital, Budapest, Hungary
J. Cummings
Affiliation:
Department of Neurology, University of California, Los Angeles, California, U.S.A.
C. Lyketsos
Affiliation:
Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. Department of Psychiatry, Johns Hopkins Bayview, Baltimore, Maryland, U.S.A.
*
Correspondence should be addressed to: Kate de Medeiros, The Copper Ridge Institute, 710 Obrecht Road, Sykesville, Maryland, 21784, U.S.A.. Phone: +1 (410) 552-3201; Fax: +1 (410) 552-0344. Email: [email protected].
Get access

Abstract

Background: Neuropsychiatric symptoms (NPS) affect almost all patients with dementia and are a major focus of study and treatment. Accurate assessment of NPS through valid, sensitive and reliable measures is crucial. Although current NPS measures have many strengths, they also have some limitations (e.g. acquisition of data is limited to informants or caregivers as respondents, limited depth of items specific to moderate dementia). Therefore, we developed a revised version of the NPI, known as the NPI-C. The NPI-C includes expanded domains and items, and a clinician-rating methodology. This study evaluated the reliability and convergent validity of the NPI-C at ten international sites (seven languages).

Methods: Face validity for 78 new items was obtained through a Delphi panel. A total of 128 dyads (caregivers/patients) from three severity categories of dementia (mild = 58, moderate = 49, severe = 21) were interviewed separately by two trained raters using two rating methods: the original NPI interview and a clinician-rated method. Rater 1 also administered four additional, established measures: the Apathy Evaluation Scale, the Brief Psychiatric Rating Scale, the Cohen-Mansfield Agitation Index, and the Cornell Scale for Depression in Dementia. Intraclass correlations were used to determine inter-rater reliability. Pearson correlations between the four relevant NPI-C domains and their corresponding outside measures were used for convergent validity.

Results: Inter-rater reliability was strong for most items. Convergent validity was moderate (apathy and agitation) to strong (hallucinations and delusions; agitation and aberrant vocalization; and depression) for clinician ratings in NPI-C domains.

Conclusion: Overall, the NPI-C shows promise as a versatile tool which can accurately measure NPS and which uses a uniform scale system to facilitate data comparisons across studies.

Keywords

dementiaAlzheimer's diseaseneuropsychiatric symptomsdepressionapathyagitationneuropsychiatric inventory
Type
Research Article
Information
International Psychogeriatrics , Volume 22 , Special Issue 6: Focus on training in psychogeriatrics , September 2010 , pp. 984 - 994
Copyright
Copyright © International Psychogeriatric Association 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1988). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23, 271–284.CrossRefGoogle ScholarPubMed
Ballard, C., Day, S., Sharp, S., Wing, G. and Sorensen, S. (2008). Neuropsychiatric symptoms in dementia: Importance and treatment considerations. International Review of Psychiatry. 20, 396–404.CrossRefGoogle ScholarPubMed
Brodaty, H. et al. (2001). Psychosis, depression and behavioral disturbances in Sydney nursing home residents: Prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504–512.CrossRefGoogle Scholar
Camozzato, A. L. et al. (2008). Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer's disease and their caregivers. International Psychogeriatrics, 20, 383–393.CrossRefGoogle ScholarPubMed
Cohen-Mansfield, J., Marx, M. S. and Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journal of Gerontology: Medical Sciences, 44, M77–M84.CrossRefGoogle ScholarPubMed
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thomson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–2314.CrossRefGoogle ScholarPubMed
Dwyer, M. and Byrne, G. J. A. (2000). Disruptive vocalization and depression in older nursing home residents. International Psychogeriatrics, 12, 463–471.CrossRefGoogle ScholarPubMed
Feldman, H. et al. (2004). Behavioral symptoms in mild cognitive impairment. Neurology, 62, 1199–1201.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. H. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Gauthier, S. et al. (2010). Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics, 22, 346–372. doi:10.1017/S1041610209991505.CrossRefGoogle ScholarPubMed
Geda, Y. E. et al. (2008). Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging. Archives of General Psychiatry, 65, 1193–1198.CrossRefGoogle ScholarPubMed
Kaufer, D. I. et al. (2000). Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 233–239.CrossRefGoogle ScholarPubMed
Lopez, O. L. et al. (2003). Psychiatry symptoms vary with the severity of dementia in probable Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 346–353.CrossRefGoogle ScholarPubMed
Lyketsos, C. G. (2007). Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. International Psychogeriatrics, 19, 409–420.CrossRefGoogle ScholarPubMed
Lyketsos, C. G. et al. (1999). Physical aggression in dementia patients and its relationship to depression. American Journal of Psychiatry, 156, 66–71.CrossRefGoogle ScholarPubMed
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. S. (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory and aging. American Journal of Psychiatry, 157, 708–714.CrossRefGoogle Scholar
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J. and DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA, 288, 1475–1483.CrossRefGoogle ScholarPubMed
Marin, R. S., Biedrzycki, R. C. and Firinciogullari, S. (1991). Reliability and validity of the Apathy Evaluation Scale. Psychiatry Research, 38, 143–162.CrossRefGoogle ScholarPubMed
Mayer, L. S. et al. (2006). Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. International Journal of Geriatric Psychiatry, 21, 930–936.CrossRefGoogle ScholarPubMed
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
Perneczky, R., Wagenpfeil, S., Komossa, K., Grimmer, T., Diehl, J. and Kurz, A. (2006). Mapping scores onto states: Mini-mental State Examination and Clinical Dementia Rating. American Journal of Geriatric Psychiatry, 14, 139–144.CrossRefGoogle ScholarPubMed
Perrault, A., Oremus, M., Demers, L., Vida, S. and Wolfson, C. (2000). Review of outcome measurement instruments in Alzehimer's disease drug trials: psychometric properties of behavior and mood scales. Journal of Geriatric Psychiatry and Neurology, 13, 181–196.CrossRefGoogle Scholar
Reisberg, B., Ferris, S. H. and De Leon, M. J. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136–1139.Google ScholarPubMed
Reisberg, B., Borenstein, J., Salob, S. P., Ferris, S. H., Franssen, E. and Georgotas, A. (1987). Behavior symptoms in Alzheimer's disease: phenomenology and treatment. Journal of Clinical Psychiatry, 48 (Suppl. 5), 9–15.Google ScholarPubMed
Reisberg, B., Auer, S. F. and Monteiro, I. (1996). Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. International Psychogeriatics, 8, 301–308.CrossRefGoogle ScholarPubMed
Robert, P. H. et al. (2009). Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. European Psychiatry, 24, 98–104.CrossRefGoogle ScholarPubMed
Rosen, W. G., Mohs, R. C. and Davis, K. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356–1364.Google ScholarPubMed
Schreinzer, D. et al. (2005). Components of behavioral pathology in dementia. International Journal of Geriatric Psychiatry, 20, 137–145.CrossRefGoogle ScholarPubMed
Sink, K. M., Holden, K. F. and Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia. JAMA, 293, 596–608.CrossRefGoogle ScholarPubMed
Starkstein, S. E. (2000). Apathy and withdrawal. International Psychogeriatrics, 12 (Suppl.1), 135–137.CrossRefGoogle Scholar
Steinberg, M. et al. (2004). The persistence of neuropsychiatric symptoms in depression: the Cache County Study. International Journal of Geriatric Psychiatry, 19, 19–26.CrossRefGoogle ScholarPubMed
Steinberg, M. et al. (2006). Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry, 21, 824–830.CrossRefGoogle ScholarPubMed
Tariot, P. N., Schneider, L. S. and Katz, I. R. (1995). Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. Journal of Geriatric Psychiatry and Neurology, 8, S28–S39.CrossRefGoogle ScholarPubMed
Ventura, J. et al. (1993). Training and quality assurance with the brief psychiatric rating scale: “the drift buster.” International Journal of Methods in Psychiatric Research, 3, 221–224.Google Scholar
Weyer, G., Erzigkeit, H., Kanowski, S., Ihl, R. and Hadler, D. (1997). Alzheimer's disease assessment scale: reliability and validity in a multicenter clinical trial. International Psychogeriatrics, 9, 123–138.CrossRefGoogle Scholar
Wilberg, T., Dammen, T. and Friis, S. (2000). Comparing personality diagnostic questionnaire 4+ with longitudinal, expert, all data (LEAD) standard diagnoses in a sample with a high prevalence of axis I and axis II disorders. Comprehensive Psychiatry, 41, 295–302.CrossRefGoogle Scholar
Supplementary material: File

Medeiros supplementary material

Medeiros supplementary material

Download Medeiros supplementary material(File)
File 71.2 KB